1. Sodium phenylbutazone, soya bean trypsin inhibitor, or the concomitant administration of ascorbic acid and mepyramine protected rats against anaphylactic shock at 10 days after sensitization but gave no protection against anaphylaxis at 20 days. 2. During anaphylactic shock in rats at 10 days after sensitization, the plasma bradykinin and bradykininogen levels, as well as those in the intestinal lumen and peritoneal cavity, were markedly raised. 3. The results support the hypothesis that there are two phases in anaphylaxis in the rat-an early phase in which bradykinin is a mediator and against which phenylbutazone or soya bean trypsin inhibitor or the mixture of ascorbic acid and mepyramine, give protection, and a late phase which does not involve bradykinin.During anaphylaxis in the rat bradykinin is formed and released in large quantities (Dawson, Starr & West, 1966). Histamine does not appear to play a major role in this type of shock as the specific antihistamine drug, mepyramine, fails to protect the animal. 5-Hydroxytryptamine also may not be involved, although its toxicity like those of bradykinin and histamine is greatly increased during the period of maximal sensitization (Sanyal & West, 1958).We have now examined the effects of another group of antagonists on the severity of anaphylactic shock in the rat, and then studied changes in the kinin and kininogen levels in certain body fluids and tissues during anaphylaxis.
MethodsGroups of ten or more male or female Wistar albino rats weighing 120-150 g were obtained from Fison's Ltd (Holmes Chapel). They were allowed free access to food and water.